AzTrials
AzTrials

Fetal Alcohol Spectrum DisordersNCT06763614

Dog Assisted Therapy: Comparing Duration Treatments for Patients with Fetal Alcohol Spectrum Disorder

A study testing Dog assisted therapy - animal interventions in people with Fetal Alcohol Spectrum Disorders, run by Hospital Universitari Vall d'Hebron Research Institute at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of the present study was to assess the efficacy of a shorter version program of Dog Assisted Therapy (DAT) (8 sessions) compared to a longer version (16 sessions) for children and adolescents with Fetal Alcohol Syndrome (FASD). Read more about this study

Who is it for?
Ages 6 to 18 years
Conditions the study is for
Fetal Alcohol Spectrum Disorders
What is being tested?
Dog assisted therapy - animal interventions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
1 siteSpain
Study dates
20 Feb 2022to 20 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Inclusion Criteria:all participants needed to have stable doses of medication for at least two months before the study and agree not to seek out any other psychiatric or psychological treatment during the study.

-

Exclusion Criteria:Patients who were not behaviorally stable, presented agressive behavior or required more intensive treatment (hospitalization or day hospital) were excluded.

-

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Universitari Vall d'Hebron

    Barcelona, Barcelona, 08035

Other trials in Spain

About this study

Official title: A Randomised Controlled Study of Dog Assisted Therapy: Comparing a Short and a Long Version Program for Patients with Fetal Alcohol Spectrum Disorder.

The objective of the present study was to assess the efficacy of a shorter version program of Dog Assisted Therapy (DAT) (8 sessions) compared to a longer version (16 sessions) for children and adolescents with Fetal Alcohol Syndrome (FASD). We evaluated the impact of DAT on social skills, internalizing and externalizing problems, quality of life, severity of the disorder and emotional well-being of parents. We conducted a randomized controlled trial in a cohort of 55 patients with FASD.

Read the detailed description

FASD can be classified into three subtypes. FAS is identified by (1) facial abnormalities, (2) growth deficits, abnormal brain development, or irregularities in neurophysiology, and (3) neurobehavioral issues. Partial Fetal Alcohol Spectrum Disorder (FASD) shares similarities but presents with fewer physical characteristics, while Alcohol-Related Neurobehavioral Disorder (ARND) solely exhibits neurobehavioral symptoms without facial anomalies.

Previous research has highlighted the effectiveness of psychological intervention programs focused on emotional regulation for individuals with FASD. Similarly, studies have emphasized the benefits of interventions targeting social skills. These interventions have been shown to result in reductions in externalizing behaviors, with social skills training specifically correlating with improvements in social competence and a decrease in problematic behaviors Recently a new form of behavioral therapy has been gaining popularity in improving the physical and mental health of young adults, known as Animal Assisted Therapy (AAT). Animal Assisted Therapy lays its foundation in human attachment theory and social cognitive theory where it is argued that animals can be potentially viewed as a transitional attachment object and thus aid to improve psychosocial functioning.

Being tested
Dog assisted therapy - animal interventions
Medical subject headings
Fetal Alcohol Spectrum Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dog assisted therapy - animal interventionsBehavioural

    Animal Assisted Therapy is when animals are used in goal directed treatment sessions. These goals are working emotionalaspects pf childres and adolescents with SAF

Study groups in NCT06763614
Study groupRoleWhat they receive
A Randomised Controlled Study Of Dog Assisted TherapyExperimentalWe tested 8 week dog assisted therapy for patients with FASD vs 16 week treatment for patients with FASD
Receives: Behavioral: Dog assisted therapy - animal interventions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Wechsler Intelligence Scale for Children

    Intellectual Quotient

    Measured: Once- Pre intervention week 1 - Post intervention in week 16

  2. Child Behavior Checklist (CBCL by Achenbach)

    Internalizing/ Externalizing Symptoms maximum scores for symptom severity 113

    Measured: Once- Pre intervention week 1 - Post intervention in week 16

  3. Social Skills Improvement System-Parent Form (SSIS-P)

    Social skills assessment - 0 to 60 max scotring

    Measured: Once- Pre intervention week 1 - Post intervention in week 16

  4. KidScreen 27- 0 maximum 135 - highest severity symptoms at 135

    Quality of life assesment

    Measured: Once- Pre intervention week 1 - Post intervention in week 16

  5. Clinical Global Impression Scale for Severity.0 to 7 (7 most severely ill).

    Severity of FASD symptoms

    Measured: Once- Pre intervention week 1 - Post intervention in week 16

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2025
  2. Study start20 Feb 2022
  3. Primary completion20 Aug 2023
  4. Study completion20 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06763614
Sponsor's protocol ID
DAT-VH-2023
Status last verified
Jul 2023
First submitted
22 Jul 2024
Last updated
8 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The data collected from the patients evaluated in our hospital will be stored in the medical records of Vall d'Hebron University Hospital, as well as in a computerized database that allows for analysis. Rigorous confidentiality of the data will be maintained in accordance with current regulations in Spain (Ley Orgánica de Protección de Datos). To analyze the final data from the three hospitals, each patient will be coded (anonymous code) to facilitate data processing.

Publications

  • Munoz-Caller S, Vidal R, Lugo J, Ristol F, Veiga A, Vico C, Ramos-Quiroga JA, Gomez-Barros N. A randomised controlled study of dog assisted therapy: comparing a short and a long version for patients with fetal alcohol spectrum disorder. Front Psychol. 2026 Apr 7;17:1720834. doi: 10.3389/fpsyg.2026.1720834. eCollection 2026.

    PubMed 42022399

Questions about this trial

What is this clinical trial studying?

A study testing Dog assisted therapy - animal interventions in people with Fetal Alcohol Spectrum Disorders, run by Hospital Universitari Vall d'Hebron Research Institute at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Wechsler Intelligence Scale for Children (time frame: Once- Pre intervention week 1 - Post intervention in week 16). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06763614, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in